The estimated Net Worth of Douglas J Seith is at least $14.4 Million dollars as of 13 September 2021. Mr. Seith owns over 21,444 units of Atricure Inc stock worth over $1,740,726 and over the last 11 years he sold ATRC stock worth over $10,561,417. In addition, he makes $2,067,400 as Chief Operating Officer at Atricure Inc.
Douglas has made over 20 trades of the Atricure Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently he sold 21,444 units of ATRC stock worth $1,619,880 on 13 September 2021.
The largest trade he's ever made was exercising 58,112 units of Atricure Inc stock on 13 June 2017 worth over $418,988. On average, Douglas trades about 8,523 units every 52 days since 2013. As of 13 September 2021 he still owns at least 64,711 units of Atricure Inc stock.
You can see the complete history of Mr. Seith stock trades at the bottom of the page.
Douglas J. Seith serves as Chief Operating Officer of the Company. Douglas J. Seith has served as our Chief Operating Officer since January 2015, having previously served as our Senior Vice President, Sales and Marketing from 2013 to 2014 and as our Vice President, United States Sales from 2011 to 2013. Since joining AtriCure in 2004 as a Regional Sales Leader, Mr. Seith has held a variety of progressive sales and sales leadership positions, including Area Director roles. Mr. Seith has over 25 years of cardiology and general surgery sales and sales leadership experience. Prior to joining AtriCure, Mr. Seith held sales leadership and/or sales positions with A-Med/EmoblX, Inc., where he was the Vice President of Sales, Heartport, Inc., Scimed Life Systems, a division of Boston Scientific, Inc. and Automated Instruments (a division of Unites States Surgical Corporation). Mr. Seith received his B.A. from Ohio Wesleyan University.
As the Chief Operating Officer of Atricure Inc, the total compensation of Douglas Seith at Atricure Inc is $2,067,400. There are 1 executives at Atricure Inc getting paid more, with Michael Carrel having the highest compensation of $5,829,780.
Douglas Seith is 54, he's been the Chief Operating Officer of Atricure Inc since 2015. There are 8 older and 4 younger executives at Atricure Inc. The oldest executive at Atricure Inc is Sven Wehrwein, 69, who is the Independent Director.
Douglas's mailing address filed with the SEC is 7555, Innovation Way, Innovation Business Center, Mason, Warren County, Ohio, 45040, United States.
Over the last 19 years, insiders at Atricure Inc have traded over $52,789,242 worth of Atricure Inc stock and bought 666,621 units worth $5,937,195 . The most active insiders traders include Scott William Drake, Group I, Llc Donoghue Danie..., and Management Group Viii L L C.... On average, Atricure Inc executives and independent directors trade stock every 24 days with the average trade being worth of $548,410. The most recent stock trade was executed by Maggie Yuen on 15 August 2024, trading 3,500 units of ATRC stock currently worth $84,245.
atricure, inc. provides innovative technologies for the treatment of afib and related conditions. afib affects more than 33 million people worldwide. electrophysiologists and cardiothoracic surgeons around the globe use atricure technologies for the treatment of afib and reduction of afib related complications. atricure’s isolator® synergy™ ablation system is the first and only medical device to receive fda approval for the treatment of persistent afib. atricure’s atriclip left atrial appendage exclusion system products are the most widely sold laa management devices worldwide, with more than 100,000 implanted to date. for more information, visit atricure.com or follow us on twitter @atricure.
Atricure Inc executives and other stock owners filed with the SEC include: